ALLURION TECHNOLOGIES, INC.

Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.

ALUR | NYSE

Overview

Corporate Details

ISIN(s):: US02008G1022
LEI:
Country:: United States of America
Address:: 11 HURON DR STE 200, 1760 NATICK
Website:: https://www.allurion.com/en
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Allurion Technologies, Inc. is a medical technology company dedicated to ending obesity. The company develops and markets the Allurion Program, a comprehensive weight-loss platform centered around the world's first and only swallowable, procedure-less gastric balloon. The program integrates the medical device with a full digital ecosystem, including the Allurion App, a Connected Scale, and an AI-powered coach, to provide real-time tracking and support. This is combined with professional nutritional coaching and medical supervision over a minimum six-month period. The platform is designed to help patients achieve and maintain metabolically healthy weight loss without surgery or endoscopy, and is available through a global network of partner clinics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ALLURION TECHNOLOGIES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLURION TECHNOLOGIES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ALLURION TECHNOLOGIES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Sequana Medical N.V. Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.	Belgium	SEQUA
SEWOONMEDICAL CO,. LTD. Researches, develops, produces, and sells high-quality consumable medical products.	South Korea	100700
Sharps Technology Inc. Develops patented safety syringes for healthcare while managing a digital asset treasury.	United States of America	STSS
SHINECO, INC. A biotech firm developing stem cell tech, POCT diagnostics, and blockchain platforms.	United States of America	SISI
SHINHUNG CO.,LTD Global manufacturer of dental implants, alloys, and surgical kits for dental professionals.	South Korea	004080
SHOFU INC. Global manufacturer of dental materials, equipment, and nail care products for dental professionals.	Japan	7979
SHOULDER INNOVATIONS, INC. Develops advanced shoulder arthroplasty implant systems for surgeons in hospitals and ASCs.	United States of America	SI
SI-BONE, Inc. Develops MIS implants for sacroiliac joint dysfunction causing chronic low back pain.	United States of America	SIBN
Sight Sciences, Inc. Develops interventional ophthalmic solutions like the OMNI® Surgical System for glaucoma.	United States of America	SGHT
Sintx Technologies, Inc. Manufactures advanced silicon nitride for biomedical, aerospace, automotive, and energy applications.	United States of America	SINT